CN106750615A - 一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 - Google Patents
一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 Download PDFInfo
- Publication number
- CN106750615A CN106750615A CN201710037849.XA CN201710037849A CN106750615A CN 106750615 A CN106750615 A CN 106750615A CN 201710037849 A CN201710037849 A CN 201710037849A CN 106750615 A CN106750615 A CN 106750615A
- Authority
- CN
- China
- Prior art keywords
- graphene
- latex
- graphene latex
- condom
- preparation technology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229910021389 graphene Inorganic materials 0.000 title claims abstract description 53
- 239000004816 latex Substances 0.000 title claims abstract description 46
- 229920000126 latex Polymers 0.000 title claims abstract description 46
- 238000005516 engineering process Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 10
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 239000003349 gelling agent Substances 0.000 claims abstract description 10
- 239000002304 perfume Substances 0.000 claims abstract description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 10
- 239000000839 emulsion Substances 0.000 claims abstract description 9
- 150000002500 ions Chemical class 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims description 15
- 239000006260 foam Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 6
- 150000001336 alkenes Chemical class 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000007711 solidification Methods 0.000 claims description 3
- 230000008023 solidification Effects 0.000 claims description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 230000004089 microcirculation Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000035699 permeability Effects 0.000 abstract description 4
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 206010043189 Telangiectasia Diseases 0.000 abstract description 3
- 208000026935 allergic disease Diseases 0.000 abstract description 3
- 230000007815 allergy Effects 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 208000009056 telangiectasis Diseases 0.000 abstract description 3
- 210000005226 corpus cavernosum Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical group [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L7/00—Compositions of natural rubber
- C08L7/02—Latex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
- A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/024—Carbon; Graphite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/34—Auxiliary operations
- B29C44/3415—Heating or cooling
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/34—Auxiliary operations
- B29C44/3442—Mixing, kneading or conveying the foamable material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/34—Auxiliary operations
- B29C44/3442—Mixing, kneading or conveying the foamable material
- B29C44/3446—Feeding the blowing agent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7538—Condoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2307/00—Characterised by the use of natural rubber
- C08J2307/02—Latex
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/04—Antistatic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Molecular Biology (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
本发明公开了一种石墨烯乳胶，包括以下重量份配比的组分，天然乳胶70～80、石墨烯0.2~0.5、硫化剂1～1.5、天然香精油0.05～0.1、胶凝剂 2～2.5、抗氧化剂0.5～0.75、硬脂酸钠 0.3～0.5,负离子粉10~15还公开了上述石墨烯乳胶的制备工艺和利用上述石墨烯乳胶制得的安全套，使石墨烯乳胶材料防螨抑菌、吸湿透气性显著提高，在20～35度状态下，对6～14微米波长的远红外光吸收率达88%以上，从而提高皮肤表面温度，使毛细血管扩张，从而促进微循环，吸湿导湿，防静电，且石墨烯乳胶材料具有高弹力，永久回弹复位，几万次的验证，回弹效果不减弱，安全套在安全套的通用基础上，更薄更坚韧，消除疲劳，提高肌体免疫力，降低过敏风险，增强海绵体膨胀，调节男性功能。
Description
技术领域
本发明涉及一种乳胶材料，还涉及一种在乳胶中加入石墨烯材料的制备工艺，还涉及一种利用该石墨烯乳胶制成的安全套。
背景技术
纯天然的乳胶在全世界上很受欢迎的天然材料之一，乳胶是由橡胶树的汁液做的，100%纯天然的乳胶，是其汁液经过全物理过程加工而成，透气性非常好。而石墨烯,是从碳材料中剥离出来的，由碳原子组成的只有一层或多层原子厚度的二维晶体，拥有非常优异和独特的光、电、磁、机械等物理性能和化学性质，被称为“新材料之王”，如果能将两者通过加工工艺混合在一起使用，用它可以制成多种保健产品，使用既舒适有健康，但是如果将两者加工混合，成为首要解决的技术问题。
发明内容
本发明所要解决的技术问题是提供一种有韧性、弹性好、抗菌消炎的石墨烯乳胶。
为解决上述技术问题，本发明的技术方案是：一种石墨烯乳胶，包括以下重量份配比的组分，
天然乳胶70～80、石墨烯0.2~0.5、硫化剂1～1.5、天然香精油0.05～0.1、胶凝剂 2～2.5、抗氧化剂0.5～0.75 、硬脂酸钠 0.3～0.5。
作为一种改进的技术方案，包括以下重量份配比的组分，
天然乳胶75、石墨烯0.3、硫化剂1.2、天然香精油0.07、胶凝剂 2.2、抗氧化剂 0.55、硬脂酸钠0.4。
本发明还涉及一种石墨烯乳胶的制备工艺，主要包括以下步骤，
步骤一、备料混合
取重量份配比的天然乳胶、石墨烯、硫化剂、天然香精油、胶凝剂、抗氧化剂和硬脂酸钠进行混合形成液体原料，导入搅拌机中搅拌均匀；
步骤二、起泡入模
在液体原料中导入氦气，并不断搅拌，形成泡沫，然后通过管道把泡沫导入模具的内腔，模具内腔注满泡沫时进行合模密封；
步骤三、加热固化
将模具移至加热室内，在加热室内充入高温蒸汽，使得模具内的泡沫固化，固化时间为2～3小时，然后移出加热室，静置冷却后打开模具，得到成形的石墨烯乳胶块；
步骤四、二次固化
再把墨烯乳胶块放入加热室内，充入高温蒸汽，5～6分钟后取出并进行清洗和干燥，得到高透气的石墨烯乳胶块。
作为一种改进的技术方案，所述步骤三和所述步骤四使用的高温蒸汽的温度为120℃ ～130℃。
本发明还公开了利用上述制备工艺制得的石墨烯乳胶制成的安全套。
作为一种改进的技术方案，所述安全套的表面涂覆有水溶性负离子粉。
由于采用了上述技术方案，本发明具有以下优点：
1、相比单纯的乳胶，石墨烯乳胶材料防螨抑菌、吸湿透气性显著提高。
2、低温远红外线，促进微循环。在20～35度状态下，对6～14微米波长的远红外光吸收率达88%以上，从而提高皮肤表面温度，使毛细血管扩张，从而促进微循环。
3、吸湿导湿，防静电。可迅速吸收人体皮肤散发的湿气汗液，并快速导入空气中散发，给身体干爽呵护。
4、石墨烯乳胶材料具有高弹力，永久回弹复位，几万次的验证，回弹效果不减弱。
石墨烯乳胶安全套，在安全套的通用基础上，更薄更坚韧，添加含有负离子粉的水溶性润滑剂后，可使海绵体在兴奋时更加膨胀，过程中，吸收远红外线，负离子，促进细胞新陈代谢，促进肌体排出有害物质，活化细胞，消除疲劳，提高肌体免疫力，降低过敏风险。
具体实施方式
下面结合实施例，进一步阐述本发明。在下面的详细描述中，只通过说明的方式描述了本发明的某些示范性实施例。毋庸置疑，本领域的普通技术人员可以认识到，在不偏离本发明的精神和范围的情况下，可以用各种不同的方式对所描述的实施例进行修正。因此，描述在本质上是说明性的，而不是用于限制权利要求的保护范围。
一种石墨烯乳胶，包括以下重量份配比的组分，
天然乳胶70～80、石墨烯0.2~0.5、硫化剂1～1.5、天然香精油0.05～0.1、胶凝剂 2～2.5、抗氧化剂0.5～0.75 、硬脂酸钠 0.3～0.5。具体地，包括以下重量份配比的组分，天然乳胶75、石墨烯0.3、硫化剂1.2、天然香精油0.07、胶凝剂 2.2、抗氧化剂 0.55、硬脂酸钠0.4。
本本实施例上述石墨烯乳胶的制备工艺，主要包括以下步骤，
步骤一、备料混合
取重量份配比的天然乳胶、石墨烯、硫化剂、天然香精油、胶凝剂、抗氧化剂和硬脂酸钠进行混合形成液体原料，导入搅拌机中搅拌均匀；
步骤二、起泡入模
在液体原料中导入氦气，并不断搅拌，形成泡沫，然后通过管道把泡沫导入模具的内腔，模具内腔注满泡沫时进行合模密封；
步骤三、加热固化
将模具移至加热室内，在加热室内充入高温蒸汽，使得模具内的泡沫固化，固化时间为2.5小时，然后移出加热室，静置冷却后打开模具，得到成形的石墨烯乳胶块；
步骤四、二次固化
再把墨烯乳胶块放入加热室内，充入高温蒸汽，5.5分钟后取出并进行清洗和干燥，得到高透气的石墨烯乳胶块。
所述步骤三和所述步骤四使用的高温蒸汽的温度为120℃ ～130℃。
本实施例生产的墨烯乳胶具有以下优点：
1、相比单纯的乳胶，石墨烯乳胶材料防螨抑菌、吸湿透气性显著提高。
2、低温远红外线，促进微循环。在20～35度状态下，对6～14微米波长的远红外光吸收率达88%以上，从而提高皮肤表面温度，使毛细血管扩张，从而促进微循环。
3、吸湿导湿，防静电。可迅速吸收人体皮肤散发的湿气汗液，并快速导入空气中散发，给身体干爽呵护。
4、石墨烯乳胶材料具有高弹力，永久回弹复位，几万次的验证，回弹效果不减弱。
本实施例还公开了利用上述制备工艺制得的石墨烯乳胶制成的安全套。
石墨烯乳胶安全套的特点：
1.原有乳胶基础上添加石墨烯成分，因石墨烯为六角分子结构，可将压力分散，增加安全套的耐压度以及韧性，更薄，更坚韧不易破损。
2.可以使石墨烯的厚度在0.335纳米，添加石墨烯的安全套，可以在保证安全性的基础上更薄。
3.添加了石墨烯的安全套，大大加强了韧性，弹力好，更加随型，不易脱落。
4.六角形分子结构，张缩有力，增加吸附感，双向受益。
5.石墨烯热导系数高，热传导性好，增强感受。
6.安全套中添加负离子粉，抗菌消炎，释放远红外线，增加海绵体膨胀，增强细胞活性。
还可以在安全套的表面涂覆水溶性负离子粉或负离子粉的水溶性化合物。
负离子粉具有以下作用：
1、使细胞活性化：通过对细胞膜促进膜内外钾、钠离子交换，保持细胞活性。
2、净化血液：通过细胞的活性化促进其新陈代谢,废物和有毒有害物质及时排出体外。
3、恢复疲劳：消除引起疲劳的致病因素，快速恢复体力。
4、稳定植物神经系统：影响植物神经系统的应激功能，调整植物神经的功能。
5、增强抗病能力：稳定情绪、增加血液中丙状球蛋白的含量、改善白细胞的数量和质量、增强白细胞吞噬细菌的功能。
6、抑制肿瘤细胞生长：影响血液中带电粒子的组分和和分布，从而使细胞体的活性增强。
7、吸收并屏蔽电磁波辐射
8、改善过敏体质：调整植物神经系统平衡，增强对变应原的抵抗力。
负离子石墨烯安全套，在安全套的通用基础上，更薄更坚韧，添加含有负离子粉的水溶性润滑剂后，可使海绵体在兴奋时更加膨胀，过程中，吸收远红外线，负离子，促进细胞新陈代谢，促进肌体排出有害物质，活化细胞，消除疲劳，提高肌体免疫力，降低过敏风险。
以上显示和描述了本发明的基本原理、主要特征及本发明的优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明精神和范围的前提下，本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (6)
1.一种石墨烯乳胶，其特征在于：包括以下重量份配比的组分，
天然乳胶70～80、石墨烯0.2~0.5、硫化剂1～1.5、天然香精油0.05～0.1、胶凝剂 2～2.5、抗氧化剂0.5～0.75 、硬脂酸钠 0.3～0.5。
2.如权利要求1所述的一种石墨烯乳胶，其特征在于：包括以下重量份配比的组分，
天然乳胶75、石墨烯0.3、硫化剂1.2、天然香精油0.07、胶凝剂 2.2、抗氧化剂 0.55、硬脂酸钠0.4。
3.如权利要求1或2所述的一种石墨烯乳胶的制备工艺，其特征在于：包括以下步骤，
步骤一、备料混合
取重量份配比的天然乳胶、石墨烯、硫化剂、天然香精油、胶凝剂、抗氧化剂和硬脂酸钠进行混合形成液体原料，导入搅拌机中搅拌均匀；
步骤二、起泡入模
在液体原料中导入氦气，并不断搅拌，形成泡沫，然后通过管道把泡沫导入模具的内腔，模具内腔注满泡沫时进行合模密封；
步骤三、加热固化
将模具移至加热室内，在加热室内充入高温蒸汽，使得模具内的泡沫固化，固化时间为2～3小时，然后移出加热室，静置冷却后打开模具，得到成形的石墨烯乳胶块；
步骤四、二次固化
再把墨烯乳胶块放入加热室内，充入高温蒸汽，5～6分钟后取出并进行清洗和干燥，得到高透气的石墨烯乳胶块。
4.如权利要求3所述的一种石墨烯乳胶的制备工艺，其特征在于：所述步骤三和所述步骤四使用的高温蒸汽的温度为120℃ ～130℃。
5.利用如权利要求3所述的制备工艺制得的石墨烯乳胶制成的安全套。
6.如权利要求4所述的一种石墨烯乳胶的制备工艺，其特征在于：所述安全套的表面涂覆有水溶性负离子粉。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710037849.XA CN106750615A (zh) | 2017-01-19 | 2017-01-19 | 一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710037849.XA CN106750615A (zh) | 2017-01-19 | 2017-01-19 | 一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106750615A true CN106750615A (zh) | 2017-05-31 |
Family
ID=58944288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710037849.XA Pending CN106750615A (zh) | 2017-01-19 | 2017-01-19 | 一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106750615A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296677A (zh) * | 2017-07-10 | 2017-10-27 | 海氏海诺乳胶（青岛）有限公司 | 一种致密内膜石墨烯避孕套的制造方法 |
| CN108641134A (zh) * | 2018-04-23 | 2018-10-12 | 青岛裕王智能科技床业有限公司 | 一种负离子乳胶记忆棉材料及应用 |
| CN110558796A (zh) * | 2019-09-23 | 2019-12-13 | 江苏金世缘乳胶制品股份有限公司 | 一种防静电天然乳胶枕头 |
| WO2022021827A1 (zh) * | 2020-07-29 | 2022-02-03 | 烯旺新材料科技股份有限公司 | 石墨烯的免疫增强新用途 |
| CN115304830A (zh) * | 2021-05-06 | 2022-11-08 | 江苏爱德福乳胶制品有限公司 | 一种石墨烯/天然乳胶复合材料制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104400956A (zh) * | 2014-11-06 | 2015-03-11 | 苏州爱马仕服饰有限公司 | 一种天然乳胶枕头的制作工艺 |
| CN105623002A (zh) * | 2015-11-27 | 2016-06-01 | 济南圣泉集团股份有限公司 | 一种含有石墨烯的乳胶及其制备方法和应用 |
| CN205586138U (zh) * | 2016-08-10 | 2016-09-21 | 张春 | 一种避孕短裤 |
-
2017
- 2017-01-19 CN CN201710037849.XA patent/CN106750615A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104400956A (zh) * | 2014-11-06 | 2015-03-11 | 苏州爱马仕服饰有限公司 | 一种天然乳胶枕头的制作工艺 |
| CN105623002A (zh) * | 2015-11-27 | 2016-06-01 | 济南圣泉集团股份有限公司 | 一种含有石墨烯的乳胶及其制备方法和应用 |
| CN205586138U (zh) * | 2016-08-10 | 2016-09-21 | 张春 | 一种避孕短裤 |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296677A (zh) * | 2017-07-10 | 2017-10-27 | 海氏海诺乳胶（青岛）有限公司 | 一种致密内膜石墨烯避孕套的制造方法 |
| CN108641134A (zh) * | 2018-04-23 | 2018-10-12 | 青岛裕王智能科技床业有限公司 | 一种负离子乳胶记忆棉材料及应用 |
| CN110558796A (zh) * | 2019-09-23 | 2019-12-13 | 江苏金世缘乳胶制品股份有限公司 | 一种防静电天然乳胶枕头 |
| CN110558796B (zh) * | 2019-09-23 | 2020-10-30 | 江苏金世缘乳胶制品股份有限公司 | 一种防静电天然乳胶枕头 |
| WO2022021827A1 (zh) * | 2020-07-29 | 2022-02-03 | 烯旺新材料科技股份有限公司 | 石墨烯的免疫增强新用途 |
| CN115304830A (zh) * | 2021-05-06 | 2022-11-08 | 江苏爱德福乳胶制品有限公司 | 一种石墨烯/天然乳胶复合材料制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106750615A (zh) | 一种石墨烯乳胶及其制备工艺及石墨烯乳胶安全套 | |
| CN104448415B (zh) | 透气性医用手套用复合材料及其制备方法 | |
| EP2068666B1 (en) | An elastomeric flexible article with absorbant polymer and manufacturing method | |
| CN103330931B (zh) | 一种防治晕车的中药香囊 | |
| WO2014063415A1 (zh) | 一种多层复合手套 | |
| CN104194342A (zh) | 海绵硅胶保健材料及其制备方法和应用 | |
| CN106750616A (zh) | 一种石墨烯乳胶及其制备工艺 | |
| De Maio et al. | 3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects | |
| CN104644520A (zh) | 一种祛痘睡眠面膜及其制备方法 | |
| CN106336536B (zh) | 一种抗菌吸汗医用橡胶手套及其制备方法 | |
| CN106700146A (zh) | 一种负离子远红外乳胶制品及其制作方法 | |
| CN105113120A (zh) | 一种吸湿排汗羽绒复合絮料及其制备方法 | |
| CN106432825A (zh) | 一种纳米活性炭在制备计生用品中的应用 | |
| CN108690274B (zh) | 一种防辐射复合胶乳及其制备方法、应用和防辐射手套 | |
| CN102117139A (zh) | 灰竹炭负离子保健鼠标垫的制备 | |
| CN109535458A (zh) | 一种负离子膜及其制备方法 | |
| CN107280851B (zh) | 一种可循环使用的硅胶发热袋的制备方法及应用 | |
| CN202859333U (zh) | 一种医用手套 | |
| CN105079423A (zh) | 一种安神中药茶及其制备方法 | |
| CN106109289A (zh) | 一种中药面霜及其制备方法 | |
| CN110251300A (zh) | 一种新型热能理疗贴制备方法 | |
| CN103980613A (zh) | 一种医用pp聚丙烯改性材料及其制备方法和用途 | |
| CN109467761A (zh) | 一种改性纳米电气石粉/肉桂提取液-胶乳抗菌膜的制备方法 | |
| CN115304830A (zh) | 一种石墨烯/天然乳胶复合材料制备方法 | |
| JP3198512U (ja) | 美容作業用手袋 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |
|
| WD01 | Invention patent application deemed withdrawn after publication |